1975
DOI: 10.1016/0006-2952(75)90186-0
|View full text |Cite
|
Sign up to set email alerts
|

Diclofenac sodium (GP 45840, voltaren), a potent inhibitor of prostaglandin synthetase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
31
0
1

Year Published

1977
1977
2017
2017

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 106 publications
(33 citation statements)
references
References 16 publications
1
31
0
1
Order By: Relevance
“…The history of diclofenac (DCL) started at early 70s when, on the basis of both experimental and clinical findings, the features of an ideal nonsteroidal anti-inflammatory drug were postulated [5][6][7][8]. They said that an effective antirheumatic agent should have an acidity constant between 4 and 5, a partition coefficient (octanol/water at pH 7.4) of c.a.…”
Section: Introductionmentioning
confidence: 99%
“…The history of diclofenac (DCL) started at early 70s when, on the basis of both experimental and clinical findings, the features of an ideal nonsteroidal anti-inflammatory drug were postulated [5][6][7][8]. They said that an effective antirheumatic agent should have an acidity constant between 4 and 5, a partition coefficient (octanol/water at pH 7.4) of c.a.…”
Section: Introductionmentioning
confidence: 99%
“…The successful effect ofdiclofenac in suppressing the inflammatory responses produced in both normal and irradiated animals might perhaps be attributed, at least in part, to its potent inhibitory effect on prostaglandin synthetase which would result in inhibition of the vasodilatation and exudation potentiating effects due to prostaglandins (Krupp et al, 1973;Ku et al, 1975); an effect common to all non-steroidal antiinflammatory drugs (Vane, 1971). Menasse et al (1978) also showed that diclofenac stabilizes lysosomal membranes and thus inhibits the release of lysosomal enzymes, which are probably responsible for the tissue destruction occurring in inflammatory rheumatic diseases.…”
Section: Discussionmentioning
confidence: 99%
“…Diclofenac [2-(2,6-dichloranilino)phenylacetic acid] is the most potent member of this class of drugs. It works by reducing the production of prostaglandins [2], the chemical that causes pain, fever and inflammation. Diclofenac blocks the enzyme (cyclooxygenase) that produces prostaglandin, resulting in decrease in production of prostaglandin and hence subsequent relief from pain.…”
Section: Introductionmentioning
confidence: 99%